The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,812.00
Bid: 1,812.00
Ask: 1,812.50
Change: 2.00 (0.11%)
Spread: 0.50 (0.028%)
Open: 1,811.00
High: 1,814.50
Low: 1,809.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Earnings, Trading Statements Calendar - Week Ahead

Mon, 27th Jul 2015 15:15

UK Earnings, Trading Statements Calendar 
Tuesday, July 28 
BPHalf Year Results
GKNHalf Year Results
NextQ2 Trading Statement
GreencoreInterim Management Statement
Provident Financial GroupHalf Year Results
Polar Capital Global Financials TrustHalf Year Results
McColl's RetailHalf Year Results
ShawbrookHalf Year Results
Virgin MoneyHalf Year Results
SEGROHalf Year Results
BrammerHalf Year Results
Tullett PrebonHalf Year Results
Rathbone BrothersHalf Year Results
InformaHalf Year Results
Domino's Pizza GroupHalf Year Results
ITVHalf Year Results
Jardine Lloyd ThompsonHalf Year Results
International Game TechnologyHalf Year Results
PaceHalf Year Results
Greencoat UK WindHalf Year Results
Burford CapitalHalf Year Results
Games Workshop Half Year Results
DraxHalf Year Results
ElementisHalf Year Results
CarpetrightHalf Year Results
Wednesday, July 29 
Brewin DolphinInterim Management Statement
Capital Counties & PropertiesHalf Year Results
AntofagastaQ2 Production Report
Compass GroupInterim Management Statement
DignityHalf Year Results
DiplomaQ3 Results
BarclaysHalf Year Results
British American TobaccoHalf Year Results
GlaxoSmithKlineQ2 Results
4imprintHalf Year Results
Jupiter Fund ManagementHalf Year Results
Lancashire HoldingsQ2 Results
RightmoveHalf Year Results
International Personal FinanceHalf Year Results
FoxtonsHalf Year Results
Pets At HomeTrading Update
Polymetal InternationalQ2 Production Report
TSB Banking GroupHalf Year Results
RenishawHalf Year Results
Tate & LyleInterim Management Statement
Tarsus GroupHalf Year Results
CapitaHalf Year Results
Taylor WimpeyHalf Year Results
Riverstone EnergyHalf Year Results
Stanley GibbonsTrading Update
Paragon GroupQ3 Interim Management Statement 
Aberforth Smaller Cos TrustHalf Year Results
SkyFull Year Results
JKX Oil & Gas Half Year Results
Circassia PharmaceuticalsHalf Year Results
St James's PlaceHalf Year Results
TymanHalf Year Results
WS AtkinsHalf Year Results
Law DebentureHalf Year Results
Mithras Investment TrustHalf Year Results
National ExpressHalf Year Results
Tullow OilHalf Year Results
Man GroupHalf Year Results
Telecity Half Year Results
Essar EnergyQ1 Results
FDM GroupHalf Year Results
IndiviorHalf Year Results
Mitchells & ButlersQ3 Interim Management Statement 
Thursday, July 30 
AstraZenecaHalf Year Results
Royal Dutch ShellHalf Year Results
CentricaHalf Year Results
Intercontinental Hotels GroupHalf Year Results
Halfords GroupQ1 Interim Management Statement 
InchcapeHalf Year Results
Moneysupermarket.comHalf Year Results
Hemderson GroupHalf Year Results
LairdHalf Year Results
Millennium & Copthorne HotelsHalf Year Results
SpectrisHalf Year Results
SchrodersHalf Year Results
BAE SystemsHalf Year Results
Rolls Royce HoldingsHalf Year Results
Royal Bank of Scotland GroupHalf Year Results
Babcock InternationalTrading Update
Smith & NephewHalf Year Results
CountrywideHalf Year Results
3i GroupInterim Management Statement
VictoriaFull Year Results
BodycoteHalf Year Results
BT GroupHalf Year Results
Centaur MediaHalf Year Results
CommunisisHalf Year Results
DiageoHalf Year Results
Intu PropertiesHalf Year Results
KAZ MineralsQ2 Production Report
Management Consulting Group Half Year Results
Merlin EntertainmentsHalf Year Results
RPS GroupHalf Year Results
Thomas CookQ3 Interim Management Statement 
Weir GroupHalf Year Results
XchangingHalf Year Results
Rentokil InitialHalf Year Results
RexamHalf Year Results
Robert WaltersHalf Year Results
Friday, July 31 
UBMHalf Year Results
BerendsenHalf Year Results
NWF GroupHalf Year Results
Colt GroupHalf Year Results
BG GroupHalf Year Results
International Consolidated Airlines GroupHalf Year Results
Lloyds Banking GroupHalf Year Results
IMIHalf Year Results
VedantaQ1 Production Results
EssentraHalf Year Results
VesuviusHalf Year Results
AlentHalf Year Results
SophosTrading Statement 
Monday, August 3 
Trinity MirrorHalf Year Results
Intertek GroupHalf Year Results
HSBC HoldingsHalf Year Results At 0500 BST
Esure GroupHalf Year Results
KellerHalf Year Results
Morgan SindallHalf Year Results
FidessaHalf Year Results
Ultra Electronics HoldingsHalf Year Results
Telit CommunicationsHalf Year Results
  
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.